Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome

Physiology and Behavior

Volumn 88, Issue 3, 2006, Pages 234-243

  Fernandez Twinn, D S ^a   Ozanne, S E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GROWTH FACTOR; MOLECULAR MARKER;

ANEMIA; ARTICLE; ASTHMA; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; COHORT ANALYSIS; ENDOTOXEMIA; ENVIRONMENTAL EXPOSURE; FAT INTAKE; GLUCOSE HOMEOSTASIS; GROWTH RETARDATION; HEART DISEASE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTHESIS; HYPOXIA; IMMUNE SYSTEM; INFECTION; INFLAMMATION; INSULIN RESISTANCE; IRON RESTRICTION; LIFESTYLE; LOW BIRTH WEIGHT; MATERNAL CARE; MATERNAL NUTRITION; MATERNAL WELFARE; METABOLIC SYNDROME X; MITOCHONDRION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; NUTRITIONAL STATUS; OBESITY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RENAL SYSTEM PARAMETERS; VALIDATION PROCESS;

EID: 33745215673     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2006.05.039     Document Type: Article

References (127)

1. Godfrey K.M., and Barker D.J. Fetal programming and adult health. Public Health Nutr 4 (2001) 611-624
2. Barker D.J., Hales C.N., Fall C.H., Osmond C., Phipps K., and Clark P.M. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993) 62-67
3. Eriksson J.G., Forsen T., Tuomilehto J., Winter P.D., Osmond C., and Barker D.J. Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 318 (1999) 427-431
4. Forsen T., Eriksson J.G., Tuomilehto J., Osmond C., and Barker D.J. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ 319 (1999) 1403-1407
5. Leon D.A., Lithell H.O., Vagero D., Koupilova I., Mohsen R., Berglund L., et al. Reduced fetal growth rate and increased risk of death from ischaemic heart disease: cohort study of 15 000 Swedish men and women born 1915-29. BMJ 317 (1998) 241-245
6. Stein C.E., Fall C.H., Kumaran K., Osmond C., Cox V., and Barker D.J. Fetal growth and coronary heart disease in south India. Lancet 348 (1996) 1269-1273
7. Laitinen J., Pietilainen K., Wadsworth M., Sovio U., and Jarvelin M.R. Predictors of abdominal obesity among 31-y-old men and women born in Northern Finland in 1966. Eur J Clin Nutr 58 (2004) 180-190
8. Leong N.M., Mignone L.I., Newcomb P.A., Titus-Ernstoff L., Baron J.A., and Trentham-Dietz A. Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer 103 (2003) 789-791
9. Innes K., Byers T., and Schymura M. Birth characteristics and subsequent risk for breast cancer in very young women. Am J Epidemiol 152 (2000) 1121-1128
10. Sanderson M., Williams M.A., Malone K.E., Stanford J.L., Emanuel I., White E., et al. Perinatal factors and risk of breast cancer. Epidemiology 7 (1996) 34-37
11. Hughson M., Farris III A.B., Douglas-Denton R., Hoy W.E., and Bertram J.F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int 63 (2003) 2113-2122
12. Luyckx V.A., and Brenner B.M. Low birth weight, nephron number, and kidney disease. Kidney Int Suppl (2005) S68-S77
13. Manalich R., Reyes L., Herrera M., Melendi C., and Fundora I. Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 58 (2000) 770-773
14. Hales C.N., Barker D.J., Clark P.M., Cox L.J., Fall C., Osmond C., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303 (1991) 1019-1022
15. Hales C.N., and Barker D.J. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35 (1992) 595-601
16. Hales C.N., and Barker D.J. The thrifty phenotype hypothesis. Br Med Bull 60 (2001) 5-20
17. Ravelli A.C., van der Meulen J.H., Michels R.P., Osmond C., Barker D.J., Hales C.N., et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet 351 (1998) 173-177
18. Bo S., Cavallo-Perin P., Scaglione L., Ciccone G., and Pagano G. Low birthweight and metabolic abnormalities in twins with increased susceptibility to Type 2 diabetes mellitus. Diabet Med 17 (2000) 365-370
19. Poulsen P., Kyvik K.O., Vaag A., and Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study. Diabetologia 42 (1999) 139-145
20. Newsome C.A., Shiell A.W., Fall C.H., Phillips D.I., Shier R., and Law C.M. Is birth weight related to later glucose and insulin metabolism?-A systematic review. Diabet Med 20 (2003) 339-348
21. Gluckman P.D., and Hanson M.A. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med 9 (2004) 419-425
22. Hattersley A.T., and Tooke J.E. The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease. Lancet 353 (1999) 1789-1792
23. Lindsay R.S., Prochazka M., Baier L.J., Knowler W.C., Bogardus C., and Hanson R.L. Currently identified genes affecting insulin resistance are not associated with birth weight in the Pima population. Diabet Med 19 (2002) 882-884
24. Eriksson J., Lindi V., Uusitupa M., Forsen T., Laakso M., Osmond C., et al. The effects of the Pro12Ala polymorphism of the PPARgamma-2 gene on lipid metabolism interact with body size at birth. Clin Genet 64 (2003) 366-370
25. Petry C.J., Ong K.K., Barratt B.J., Wingate D., Cordell H.J., Ring S.M., et al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet 6 (2005) 22
26. Ballew C., and Haas J.D. Hematologic evidence of fetal hypoxia among newborn infants at high altitude in Bolivia. Am J Obstet Gynecol 155 (1986) 166-169
27. Habek D., Habek J.C., Ivanisevic M., and Djelmis J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn Ther 17 (2002) 367-371
28. Ong K.K., Preece M.A., Emmett P.M., Ahmed M.L., and Dunger D.B. Size at birth and early childhood growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort study and analysis. Pediatr Res 52 (2002) 863-867
29. Montgomery S.M., and Ekbom A. Smoking during pregnancy and diabetes mellitus in a British longitudinal birth cohort. BMJ 324 (2002) 26-27
30. Toschke A.M., Ehlin A.G., von Kries R., Ekbom A., and Montgomery S.M. Maternal smoking during pregnancy and appetite control in offspring. J Perinat Med 31 (2003) 251-256
31. Montgomery S.M., Ehlin A., and Ekbom A. Smoking during pregnancy and bulimia nervosa in offspring. J Perinat Med 33 (2005) 206-211
32. Scholl T.O., and Hediger M.L. Anemia and iron-deficiency anemia: compilation of data on pregnancy outcome. Am J Clin Nutr 59 (1994) 492S-500S [discussion 500S-501S]
33. Moreu G., Tellez L., and Gonzalez-Jaranay M. Relationship between maternal periodontal disease and low-birth-weight pre-term infants. J Clin Periodontol 32 (2005) 622-627
34. Becroft D.M., Thompson J.M., and Mitchell E.A. Placental villitis of unknown origin: epidemiologic associations. Am J Obstet Gynecol 192 (2005) 264-271
35. Dewyea V.A., Nelson M.R., and Martin B.L. Asthma in pregnancy. Allergy Asthma Proc 26 (2005) 323-325
36. Bispham J., Gardner D.S., Gnanalingham M.G., Stephenson T., Symonds M.E., and Budge H. Maternal nutritional programming of fetal adipose tissue development: differential effects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferator-activated and prolactin receptors. Endocrinology 146 (2005) 3943-3949
37. Muhlhausler B.S., Adam C.L., Marrocco E.M., Findlay P.A., Roberts C.T., McFarlane J.R., et al. Impact of glucose infusion on the structural and functional characteristics of adipose tissue and on hypothalamic gene expression for appetite regulatory neuropeptides in the sheep fetus during late gestation. J Physiol 565 (2005) 185-195
38. Gardner D.S., Tingey K., Van Bon B.W., Ozanne S.E., Wilson V., Dandrea J., et al. Programming of glucose-insulin metabolism in adult sheep after maternal undernutrition. Am J Physiol Regul Integr Comp Physiol 289 (2005) R947-R954
39. Ross M.G., Desai M., Guerra C., and Wang S. Programmed syndrome of hypernatremic hypertension in ovine twin lambs. Am J Obstet Gynecol 192 (2005) 1196-1204
40. Poore K.R., and Fowden A.L. The effect of birth weight on hypothalamo-pituitary-adrenal axis function in juvenile and adult pigs. J Physiol 547 (2003) 107-116
41. Poore K.R., and Fowden A.L. The effect of birth weight on glucose tolerance in pigs at 3 and 12 months of age. Diabetologia 45 (2002) 1247-1254
42. Poore K.R., and Fowden A.L. Insulin sensitivity in juvenile and adult Large White pigs of low and high birthweight. Diabetologia 47 (2004) 340-348
43. Corstius H.B., Zimanyi M.A., Maka N., Herath T., Thomas W., van der Laarse A., et al. Effect of intrauterine growth restriction on the number of cardiomyocytes in rat hearts. Pediatr Res 57 (2005) 796-800
44. Garofano A., Czernichow P., and Breant B. In utero undernutrition impairs rat beta-cell development. Diabetologia 40 (1997) 1231-1234
45. Garofano A., Czernichow P., and Breant B. Beta-cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 41 (1998) 1114-1120
46. Vickers M.H., Breier B.H., Cutfield W.S., Hofman P.L., and Gluckman P.D. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 279 (2000) E83-E87
47. Vickers M.H., Ikenasio B.A., and Breier B.H. IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 142 (2001) 3964-3973
48. Vickers M.H., Gluckman P.D., Coveny A.H., Hofman P.L., Cutfield W.S., Gertler A., et al. Neonatal leptin treatment reverses developmental programming. Endocrinology 146 (2005) 4211-4216
49. Haggarty P., Allstaff S., Hoad G., Ashton J., and Abramovich D.R. Placental nutrient transfer capacity and fetal growth. Placenta 23 (2002) 86-92
50. Wigglesworth J.S. Fetal growth retardation. Animal model: uterine vessel ligation in the pregnant rat. Am J Pathol 77 (1974) 347-350
51. De Prins F.A., and Van Assche F.A. Intrauterine growth retardation and development of endocrine pancreas in the experimental rat. Biol Neonate 41 (1982) 16-21
52. Styrud J., Eriksson U.J., Grill V., and Swenne I. Experimental intrauterine growth retardation in the rat causes a reduction of pancreatic B-cell mass, which persists into adulthood. Biol Neonate 88 (2005) 122-128
53. Simmons R.A., Templeton L.J., and Gertz S.J. Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes 50 (2001) 2279-2286
54. Merlet-Benichou C., Gilbert T., Muffat-Joly M., Lelievre-Pegorier M., and Leroy B. Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol 8 (1994) 175-180
55. Schreuder M.F., Nyengaard J.R., Fodor M., van Wijk J.A., and Delemarre-van de Waal H.A. Glomerular number and function are influenced by spontaneous and induced low birth weight in rats. J Am Soc Nephrol 16 (2005) 2913-2919
56. Boloker J., Gertz S.J., and Simmons R.A. Gestational diabetes leads to the development of diabetes in adulthood in the rat. Diabetes 51 (2002) 1499-1506
57. Holemans K., Aerts L., and Van Assche F.A. Fetal growth restriction and consequences for the offspring in animal models. J Soc Gynecol Investig 10 (2003) 392-399
58. Evers I.M., de Valk H.W., Mol B.W., ter Braak E.W., and Visser G.H. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 45 (2002) 1484-1489
59. Savona-Ventura C., and Chircop M. Birth weight influence on the subsequent development of gestational diabetes mellitus. Acta Diabetol 40 (2003) 101-104
60. Pettitt D.J., Narayan K.M., Hanson R.L., and Knowler W.C. Incidence of diabetes mellitus in women following impaired glucose tolerance in pregnancy is lower than following impaired glucose tolerance in the non-pregnant state. Diabetologia 39 (1996) 1334-1337
61. Williams M.A., Emanuel I., Kimpo C., Leisenring W.M., and Hale C.B. A population-based cohort study of the relation between maternal birthweight and risk of gestational diabetes mellitus in four racial/ethnic groups. Paediatr Perinat Epidemiol 13 (1999) 452-465
62. Aerts L., and Van Assche F.A. Is gestational diabetes an acquired condition?. J Dev Physiol 1 (1979) 219-225
63. Holemans K., Aerts L., and Van Assche F.A. Evidence for an insulin resistance in the adult offspring of pregnant streptozotocin-diabetic rats. Diabetologia 34 (1991) 81-85
64. Van Assche F.A., Holemans K., and Aerts L. Fetal growth and consequences for later life. J Perinat Med 26 (1998) 337-346
65. Dorner G., Plagemann A., and Reinagel H. Familial diabetes aggregation in type I diabetics: gestational diabetes an apparent risk factor for increased diabetes susceptibility in the offspring. Exp Clin Endocrinol 89 (1987) 84-90
66. Giussani D.A., Phillips P.S., Anstee S., and Barker D.J. Effects of altitude versus economic status on birth weight and body shape at birth. Pediatr Res 49 (2001) 490-494
67. Li G., Xiao Y., Estrella J.L., Ducsay C.A., Gilbert R.D., and Zhang L. Effect of fetal hypoxia on heart susceptibility to ischemia and reperfusion injury in the adult rat. J Soc Gynecol Investig 10 (2003) 265-274
68. Peyronnet J., Dalmaz Y., Ehrstrom M., Mamet J., Roux J.C., Pequignot J.M., et al. Long-lasting adverse effects of prenatal hypoxia on developing autonomic nervous system and cardiovascular parameters in rats. Pflugers Arch 443 (2002) 858-865
69. Jones R.D., Morice A.H., and Emery C.J. Effects of perinatal exposure to hypoxia upon the pulmonary circulation of the adult rat. Physiol Res 53 (2004) 11-17
70. Zhang L. Prenatal hypoxia and cardiac programming. J Soc Gynecol Investig 12 (2005) 2-13
71. Rasmussen K. Is there a causal relationship between iron deficiency or iron-deficiency anemia and weight at birth, length of gestation and perinatal mortality?. J Nutr 131 (2001) 590S-601S [discussion 601S-603S]
72. Kadyrov M., Kosanke G., Kingdom J., and Kaufmann P. Increased fetoplacental angiogenesis during first trimester in anaemic women. Lancet 352 (1998) 1747-1749
73. Lewis R.M., James L.A., Zhang J., Byrne C.D., and Hales C.N. Effects of maternal iron restriction in the rat on hypoxia-induced gene expression and fetal metabolite levels. Br J Nutr 85 (2001) 193-201
74. Lisle S.J., Lewis R.M., Petry C.J., Ozanne S.E., Hales C.N., and Forhead A.J. Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Br J Nutr 90 (2003) 33-39
75. Zhang J., Lewis R.M., Wang C., Hales N., and Byrne C.D. Maternal dietary iron restriction modulates hepatic lipid metabolism in the fetuses. Am J Physiol Regul Integr Comp Physiol 288 (2005) R104-R111
76. Allen L.H. Biological mechanisms that might underlie iron's effects on fetal growth and preterm birth. J Nutr 131 (2001) 581S-589S
77. Nilsson C., Larsson B.M., Jennische E., Eriksson E., Bjorntorp P., York D.A., et al. Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 142 (2001) 2622-2630
78. Reinisch J.M., Simon N.G., Karow W.G., and Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202 (1978) 436-438
79. O'Regan D., Kenyon C.J., Seckl J.R., and Holmes M.C. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology. Am J Physiol Endocrinol Metab 287 (2004) E863-E870
80. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., and Edwards C.R. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341 (1993) 339-341
81. Lindsay R.S., Lindsay R.M., Waddell B.J., and Seckl J.R. Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39 (1996) 1299-1305
82. Seckl J.R. Prenatal glucocorticoids and long-term programming. Eur J Endocrinol 151 Suppl. 3 (2004) U49-U62
83. McMullen S., and Langley-Evans S.C. Sex-specific effects of prenatal low-protein and carbenoxolone exposure on renal angiotensin receptor expression in rats. Hypertension 46 (2005) 1374-1380
84. Newman III W.P., Freedman D.S., Voors A.W., Gard P.D., Srinivasan S.R., Cresanta J.L., et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314 (1986) 138-144
85. Brown S.A., Rogers L.K., Dunn J.K., Gotto Jr. A.M., and Patsch W. Development of cholesterol homeostatic memory in the rat is influenced by maternal diets. Metabolism 39 (1990) 468-473
86. Guo F., and Jen K.L. High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol Behav 57 (1995) 681-686
87. Khan I.Y., Taylor P.D., Dekou V., Seed P.T., Lakasing L., Graham D., et al. Gender-linked hypertension in offspring of lard-fed pregnant rats. Hypertension 41 (2003) 168-175
88. Khan I.Y., Dekou V., Douglas G., Jensen R., Hanson M.A., Poston L., et al. A high-fat diet during rat pregnancy or suckling induces cardiovascular dysfunction in adult offspring. Am J Physiol Regul Integr Comp Physiol 288 (2005) R127-R133
89. Buckley A.J., Keseru B., Briody J., Thompson M., Ozanne S.E., and Thompson C.H. Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism 54 (2005) 500-507
90. Snoeck A., Remacle C., Reusens B., and Hoet J.J. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 57 (1990) 107-118
91. Dahri S., Snoeck A., Reusens-Billen B., Remacle C., and Hoet J.J. Islet function in offspring of mothers on low-protein diet during gestation. Diabetes 40 Suppl. 2 (1991) 115-120
92. Fernandez-Twinn D.S., Ozanne S.E., Ekizoglou S., Doherty C., James L., Gusterson B., et al. The maternal endocrine environment in the low-protein model of intra-uterine growth restriction. Br J Nutr 90 (2003) 815-822
93. Hales C.N., Desai M., Ozanne S.E., and Crowther N.J. Fishing in the stream of diabetes: from measuring insulin to the control of fetal organogenesis. Biochem Soc Trans 24 (1996) 341-350
94. Ozanne S.E., Wang C.L., Petry C.J., Smith J.M., and Hales C.N. Ketosis resistance in the male offspring of protein-malnourished rat dams. Metabolism 47 (1998) 1450-1454
95. Shepherd P.R., Crowther N.J., Desai M., Hales C.N., and Ozanne S.E. Altered adipocyte properties in the offspring of protein malnourished rats. Br J Nutr 78 (1997) 121-129
96. Petry C.J., Dorling M.W., Pawlak D.B., Ozanne S.E., and Hales C.N. Diabetes in old male offspring of rat dams fed a reduced protein diet. Int J Exp Diabetes Res 2 (2001) 139-143
97. Fernandez-Twinn D.S., Wayman A., Ekizoglou S., Martin M.S., Hales C.N., and Ozanne S.E. Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring. Am J Physiol Regul Integr Comp Physiol 288 (2005) R368-R373
98. Ozanne S.E., Olsen G.S., Hansen L.L., Tingey K.J., Nave B.T., Wang C.L., et al. Early growth restriction leads to down regulation of protein kinase C zeta and insulin resistance in skeletal muscle. J Endocrinol 177 (2003) 235-241
99. Ozanne S.E., Dorling M.W., Wang C.L., and Nave B.T. Impaired PI 3-kinase activation in adipocytes from early growth-restricted male rats. Am J Physiol Endocrinol Metab 280 (2001) E534-E539
100. Ozanne S.E., Dorling M.W., Wang C.L., and Petry C.J. Depot-specific effects of early growth retardation on adipocyte insulin action. Horm Metab Res 32 (2000) 71-75
101. Ryder J.W., Gilbert M., and Zierath J.R. Skeletal muscle and insulin sensitivity: pathophysiological alterations. Front Biosci 6 (2001) D154-D163
102. Jensen C.B., Storgaard H., Dela F., Holst J.J., Madsbad S., and Vaag A.A. Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 51 (2002) 1271-1280
103. Ozanne S.E., Jensen C.B., Tingey K.J., Storgaard H., Madsbad S., and Vaag A.A. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia 48 (2005) 547-552
104. Ozanne S.E., Lewis R., Jennings B.J., and Hales C.N. Early programming of weight gain in mice prevents the induction of obesity by a highly palatable diet. Clin Sci (Lond) 106 (2004) 141-145
105. Winick M., and Noble A. Cellular response in rats during malnutrition at various ages. J Nutr 89 (1966) 300-306
106. Arenz S., Ruckerl R., Koletzko B., and von Kries R. Breast-feeding and childhood obesity-a systematic review. Int J Obes Relat Metab Disord 28 (2004) 1247-1256
107. Koletzko B., Broekaert I., Demmelmair H., Franke J., Hannibal I., Oberle D., et al. Protein intake in the first year of life: a risk factor for later obesity? The E.U. childhood obesity project. Adv Exp Med Biol 569 (2005) 69-79
108. Savino F., Nanni G.E., Maccario S., Costamagna M., Oggero R., and Silvestro L. Breast-fed infants have higher leptin values than formula-fed infants in the first four months of life. J Pediatr Endocrinol Metab 17 (2004) 1527-1532
109. Cripps R.L., Martin-Gronert M.S., and Ozanne S.E. Fetal and perinatal programming of appetite. Clin Sci (Lond) 109 (2005) 1-11
110. Davidowa H., Li Y., and Plagemann A. Altered responses to orexigenic (AGRP, MCH) and anorexigenic (alpha-MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats. Eur J Neurosci 18 (2003) 613-621
111. McMillen I.C., Adam C.L., and Muhlhausler B.S. Early origins of obesity: programming the appetite regulatory system. J Physiol 565 (2005) 9-17
112. Fowden A.L., Giussani D.A., and Forhead A.J. Endocrine and metabolic programming during intrauterine development. Early Hum Dev 81 (2005) 723-734
113. Luo Z.C., Fraser W.D., Julien P., Deal C.L., Audibert F., Smith G.N., et al. Tracing the origins of "fetal origins" of adult diseases: Programming by oxidative stress?. Med Hypotheses 66 (2006) 38-44
114. Roberts J.M., and Lain K.Y. Recent Insights into the pathogenesis of pre-eclampsia. Placenta 23 (2002) 359-372
115. Peuchant E. Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes. Clin Biochem 37 (2004) 293-298
116. Gupta P., Narang M., Banerjee B.D., and Basu S. Oxidative stress in term small for gestational age neonates born to undernourished mothers: a case control study. BMC Pediatr 4 (2004) 14
117. Baydas G., Karatas F., Gursu M.F., Bozkurt H.A., Ilhan N., Yasar A., et al. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res 33 (2002) 276-280
118. Franco Mdo C., Dantas A.P., Akamine E.H., Kawamoto E.M., Fortes Z.B., Scavone C., et al. Enhanced oxidative stress as a potential mechanism underlying the programming of hypertension in utero. J Cardiovasc Pharmacol 40 (2002) 501-509
119. Racasan S., Braam B., van der Giezen D.M., Goldschmeding R., Boer P., Koomans H.A., et al. Perinatal l-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats. Hypertension 44 (2004) 83-88
120. Drake A.J., Walker B.R., and Seckl J.R. Intergenerational consequences of fetal programming by in utero exposure to glucocorticoids in rats. Am J Physiol Regul Integr Comp Physiol 288 (2005) R34-R38
121. Junien C., Gallou-Kabani C., Vige A., and Gross M.S. Nutritional epigenomics of metabolic syndrome. Med Sci (Paris) 21 (2005) 396-404
122. Saldana T.M., Siega-Riz A.M., and Adair L.S. Effect of macronutrient intake on the development of glucose intolerance during pregnancy. Am J Clin Nutr 79 (2004) 479-486
123. Catalano P.M., Thomas A., Huston-Presley L., and Amini S.B. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189 (2003) 1698-1704
124. Laviola L., Perrini S., Belsanti G., Natalicchio A., Montrone C., Leonardini A., et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146 (2005) 1498-1505
125. Das U.N. A perinatal strategy to prevent coronary heart disease. Nutrition 19 (2003) 1022-1027
126. Fraser WD, Xiong X, Julien P, Smith GN, Walker M, Benjamin A. et al. International trial for the prevention of preeclampsia.Funded by Canadian Institutes of Health Research (2003-2008).
127. Raijmakers M.T., Dechend R., and Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension 44 (2004) 374-380